These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2746595)

  • 1. Deficiency of the 9th component of complement (C9) in a patient with systemic lupus erythematosus.
    Kawai T; Katoh K; Narita M; Tani K; Okubo T
    J Rheumatol; 1989 Apr; 16(4):542-3. PubMed ID: 2746595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case of systemic lupus erythematosus in late component (C9) complement deficiency].
    Takeda I; Igarashi S; Nishimaki T; Kasukawa R
    Ryumachi; 1994 Jun; 34(3):628-32. PubMed ID: 8052928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent meningitis in a patient with congenital deficiency of the C9 component of complement. First case of C9 deficiency in Europe.
    Zoppi M; Weiss M; Nydegger UE; Hess T; Späth PJ
    Arch Intern Med; 1990 Nov; 150(11):2395-9. PubMed ID: 2241452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deficiency of the ninth component of complement in man.
    Inai S; Kitamura H; Hiramatsu S; Nagaki K
    J Clin Lab Immunol; 1979 Apr; 2(1):85-7. PubMed ID: 95812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioimmunoassay of the attack complex of complement in serum from patients with systemic lupus erythematosus.
    Falk RJ; Dalmasso AP; Kim Y; Lam S; Michael A
    N Engl J Med; 1985 Jun; 312(25):1594-9. PubMed ID: 4000197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of C1q polymorphisms suggests association with systemic lupus erythematosus, serum C1q and CH50 levels and disease severity.
    Martens HA; Zuurman MW; de Lange AH; Nolte IM; van der Steege G; Navis GJ; Kallenberg CG; Seelen MA; Bijl M
    Ann Rheum Dis; 2009 May; 68(5):715-20. PubMed ID: 18504288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Which complement assays and typings are necessary for the diagnosis of complement deficiency in patients with lupus erythematosus? A study of 25 patients.
    Boeckler P; Meyer A; Uring-Lambert B; Goetz J; Cribier B; Hauptmann G; Lipsker D
    Clin Immunol; 2006 Nov; 121(2):198-202. PubMed ID: 16987709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement component 9 deficiency is not a susceptibility factor for SLE.
    Kanemitsu S; Ihara K; Kira R; Kaku Y; Sakai K; Tsuzaka K; Takeuchi T; Hara T
    Lupus; 2000; 9(6):456-7. PubMed ID: 10981651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of C9 in complement-mediated killing of Neisseria.
    Harriman GR; Esser AF; Podack ER; Wunderlich AC; Braude AI; Lint TF; Curd JG
    J Immunol; 1981 Dec; 127(6):2386-90. PubMed ID: 6795273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic lupus erythematosus in a patient with C4 deficiency.
    Urowitz MB; Gladman DD; Minta JO
    J Rheumatol; 1981; 8(5):741-6. PubMed ID: 6975824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective deficiency of the fourth component of complement in a patient with systemic lupus erythematosus (SLE): immunochemical and biological studies.
    Minta JO; Urowitz MB; Gladman DD; Irizawa T; Biggar WD
    Clin Exp Immunol; 1981 Jul; 45(1):72-80. PubMed ID: 6796316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further studies on C9 deficiency.
    Kitamura H; Nagaki K; Inai S
    J Clin Lab Immunol; 1981 Jul; 6(1):7-11. PubMed ID: 7265179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Observation of the third component of complement (C3) and total hemolytic complement (CH50) in serum with SLE].
    Jin A; Chen P; Ke X; Yu M; Fan L; Zhang N; Hou J; Ling Y
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1982 Oct; 4(5):322-3. PubMed ID: 6219771
    [No Abstract]   [Full Text] [Related]  

  • 14. Deficiency of C2, the second complement component, in the family of a patient with SLE-like syndrome: the first case of hereditary C2 deficiency in Czechoslovakia.
    Starsia Z; Zitnan D; Loos M; Stefanovic J; Bosák V; Niks M; Tomanová H; Lukác J; Lulovicová M
    Haematologia (Budap); 1987; 20(4):215-20. PubMed ID: 3428724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The association between deficiency of terminal complement components and the occurrence of meningococcal meningitis].
    Nishizaki M
    Fukuoka Igaku Zasshi; 1992 May; 83(5):201-8. PubMed ID: 1612549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inherited deficiency of the ninth component of complement in man.
    Lint TF; Zeitz HJ; Gewurz H
    J Immunol; 1980 Nov; 125(5):2252-7. PubMed ID: 7430628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The metabolism of C9 in normal subjects and in patients with autoimmune disease.
    Greenstein JD; Peake PW; Charlesworth JA
    Clin Exp Immunol; 1996 Apr; 104(1):160-6. PubMed ID: 8603521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Terminal complement complex in plasma from patients with systemic lupus erythematosus and other glomerular diseases.
    Horigome I; Seino J; Sudo K; Kinoshita Y; Saito T; Yoshinaga K
    Clin Exp Immunol; 1987 Nov; 70(2):417-24. PubMed ID: 3427827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acquired C1-inhibitor deficiency in a patient with systemic lupus erythematosus: a case report and review of the literature.
    Nettis E; Colanardi MC; Loria MP; Vacca A
    Eur J Clin Invest; 2005 Dec; 35(12):781-4. PubMed ID: 16313255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients with systemic lupus erythematosus are deficient in complement-dependent prevention of immune precipitation.
    Arason GJ; Steinsson K; Kolka R; Víkingsdóttir T; D'Ambrogio MS; Valdimarsson H
    Rheumatology (Oxford); 2004 Jun; 43(6):783-9. PubMed ID: 15054157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.